当前位置： SCI文献检索 > EUROPEAN UROLOGY期刊下所有文献 > Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapy.

Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapy.

Abstract：

OBJECTIVES:Osteocalcin is a vitamin-K dependent protein which is related to the metabolism of bone and calcium. The formation or progression of prostate cancer is presumed to be associated with the osteocalcin gene. The most frequently seen polymorphism is HindIII which is located at the promoter region. HindIII is therefore a possible genetic marker in the search for the association between prostate cancer and normal control subjects. METHODS:In our study, a normal control group of 132 healthy people and 96 patients with prostate cancer were examined. The polymorphism was seen following polymerase chain reaction (PCR) based restriction analysis. RESULTS:The result revealed significant differences between normal individuals and cancer patients (p=0.034) and the distribution of the "CC" homozygote in the control group was higher than that in the patient group. No statistical differences were found in clinical staging and grading. The 54 patients who received hormone therapy were further categorized into response and non-response groups, statistical differences between these two groups were revealed (p=0.007, Fisher's exact test). CONCLUSIONS:Based on our results, we conclude that the HindIII polymorphism of the osteocalcin gene is a suitable genetic marker of prostate cancer which can be used in the prediction of the outcome of patients who receive hormone therapy.

journal_name

Eur Urol

journal_title

European urology

authors

Wu HC,Lin CC,Chen WC,Chen HY,Tsai FJ

doi

10.1016/s0302-2838(02)00541-9

keywords:

subject

Has Abstract

pub_date

2003-02-01 00:00:00

pages

197-200

issue

2

eissn

0302-2838

issn

1873-7560

pii

S0302283802005419

journal_volume

43

pub_type

杂志文章

相关文献

EUROPEAN UROLOGY文献大全
  • Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature.

    abstract：OBJECTIVES:Eighty per cent of the newly diagnosed invasive bladder tumours are invasive from the outset. Half of these patients already have occult distant metastases reflecting the rapid nature of progression. The aim of the current study was to review the literature to determine if delay in cystectomy leads to worse ...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2006.05.046

    authors： Fahmy NM,Mahmud S,Aprikian AG

    更新日期：2006-12-01 00:00:00

  • Prevention of bacterial resistance in urinary tract infections.

    abstract：:Recurrences of urinary tract infection (UTI) are frequent in many segments of the population. Most women with recurrent UTI have normal genitourinary tracts, and infection is thought to emanate from the fecal bacterial reservoir, with subsequent vaginal and periurethral colonization. The fluoroquinolones, e.g., norflo...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1159/000473673

    authors： Goldstein EJ

    更新日期：1991-01-01 00:00:00

  • Results of fibrin glue application therapy in testicular hydrocele.

    abstract：:Nine patients, mean age 55 years, with testicular hydroceles, were treated by aspiration and two-component fibrin glue injection. One patient was treated twice. The glue contains 70-110 mg fibrinogen and 500 IU human thrombin in 0.5- and 2-ml injections, respectively (Tisseel duo quick, Immune AB). The smaller glue vo...

    journal_title：European urology

    pub_type： 临床试验,杂志文章

    doi：10.1159/000019641

    authors： Sirpa A,Martti AO

    更新日期：1998-01-01 00:00:00

  • Tumor collagenase-stimulating factor and tumor autocrine motility factor as tumor markers in bladder cancer--an update.

    abstract：:We have studied the role of combined measurements of tumor collagenase-stimulating factor (TCSF) and tumor autocrine motility factor (TAMF) in 83 first morning voids and 24-hour specimens in patients with bladder and renal cancer and control subjects. TCSF and TAMF were measured by immunoabsorption assay and motility ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000474877

    authors： Javadpour N,Guirguis R

    更新日期：1992-01-01 00:00:00

  • Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma.

    abstract：:Cytogenetic and flow cytometric DNA analyses were performed on 37 tumor samples from 16 patients with renal cell carcinoma. 36 cultures were chromosomally abnormal and 1 was normal. The most frequent abnormality was trisomy or tetrasomy of chromosome 7 (13 of 16 tumors), suggesting that this abnormality might be a pri...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000473581

    authors： Ljungberg B,Nordenson I,Roos G

    更新日期：1991-01-01 00:00:00

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

    abstract：CONTEXT:This overview presents the updated European Association of Urology (EAU) guidelines for non-muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ (CIS). OBJECTIVE:To provide practical recommendations on the clinical management of NMIBC with a focus on clinical presentation and recommendations. E...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2019.08.016

    authors： Babjuk M,Burger M,Compérat EM,Gontero P,Mostafid AH,Palou J,van Rhijn BWG,Rouprêt M,Shariat SF,Sylvester R,Zigeuner R,Capoun O,Cohen D,Escrig JLD,Hernández V,Peyronnet B,Seisen T,Soukup V

    更新日期：2019-11-01 00:00:00

  • Significant antitumor effect of intratumoral ethanol injection on renal cell carcinoma.

    abstract：OBJECTIVE:The effects of intratumoral ethanol injection on renal cell carcinoma (RCC) heterotransplanted in nude rats were evaluated. MATERIALS AND METHODS:The OUR95AF human RCC cell line was inoculated subcutaneously into the backs of nude rats. Four weeks after transplantation, the size of tumors became 1.5-2.0 cm i...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/s0302-2838(03)00354-3

    authors： Naitoh Y,Kawauchi A,Mizutani Y,Ukimura O,Fujito A,Nakao M,Kojima Y,Nonomura N,Okuyama A,Miki T

    更新日期：2003-10-01 00:00:00

  • Hormonal pattern and testicular histology in patients with prostatic cancer after long-term treatment with a gonadotropin-releasing hormone agonist analogue.

    abstract：:Seven patients suffering from prostatic cancer were treated with a depot form of D-Trp-6-luteinizing hormone-releasing hormone (LH-RH), a LH-RH agonist analogue (3 mg i.m. every 28 days) for a period of 24-32 months. The peptide induced a sharp and long-lasting inhibition of both gonadotropin and testosterone secretio...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000473411

    authors： Giberti C,Barreca T,Martorana G,Truini M,Franceschini R,Rolandi E,Giuliani L

    更新日期：1988-01-01 00:00:00

  • Leiomyosarcoma of the prostate: a case report.

    abstract：:A case of leiomyosarcoma of the prostate in a 26-year-old man is presented. The short duration of symptoms, the typical sensation at rectal palpation, and the sudden fast increase in growth are stressed. The bad prognosis justifies an agressive therapeutical approach. ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000472139

    authors： Vereecken RL,Lauweryns J,Drochmans A,Van Dijck X

    更新日期：1977-01-01 00:00:00

  • BCG treatment of existing Ta, T1 tumours or carcinoma in situ of the bladder.

    abstract：:There are theoretical limits to the efficacy of intravesical instillation of anticancer agents as a method to prevent recurrence of superficial bladder cancer. Studies on the direct efficacy of intravesical instillation of bacillus Calmette-Guérin (BCG) to treat existing papillary tumours (Ta, T1) have shown a complet...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1159/000475202

    authors： Akaza H

    更新日期：1995-01-01 00:00:00

  • Is the diet of patients with interstitial cystitis related to their disease?

    abstract：OBJECTIVE:The dietary habits of interstitial cystitis (IC) patients compared to the average food and fluid consumption of the general population were evaluated and any spontaneous preference or avoidance of specific foodstuffs and fluids of IC patients was investigated. METHODS:A verbal interview with 16 IC patients p...

    journal_title：European urology

    pub_type： 杂志文章

    doi：

    authors： Bade JJ,Peeters JM,Mensink HJ

    更新日期：1997-01-01 00:00:00

  • ETS gene fusions in prostate cancer: from discovery to daily clinical practice.

    abstract：CONTEXT:In 2005, fusions between the androgen-regulated transmembrane protease serine 2 gene, TMPRSS2, and E twenty-six (ETS) transcription factors were discovered in prostate cancer. OBJECTIVE:To review advances in our understanding of ETS gene fusions, focusing on challenges affecting translation to clinical applica...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2009.04.036

    authors： Tomlins SA,Bjartell A,Chinnaiyan AM,Jenster G,Nam RK,Rubin MA,Schalken JA

    更新日期：2009-08-01 00:00:00

  • Surgical treatment of rectourethral fistulae.

    abstract：:9 male patients with rectourethral fistula were treated. Fistulae were congenital in 1 case, iatrogenic in 6 cases and traumatic in 2 cases. In 8 cases we used an abdominoperineal approach with omentoplasty or peritoneal flap; in 1 case a perineal approach was made. In 2 cases it was also necessary to use a transpubic...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000472547

    authors： Trippitelli A,Barbagli G,Lenzi R,Fiorelli C,Masini GC

    更新日期：1985-01-01 00:00:00

  • Trastuzumab (Herceptin) in metastatic transitional cell carcinoma of the urinary tract: report on six patients.

    abstract：OBJECTIVE:To report our preliminary experience with trastuzumab (Herceptin) in the management of metastatic transitional cell carcinoma of the urinary tract. PATIENTS AND METHODS:From november 2001 to august 2002, six patients received trastuzumab for metastatic transitional cell carcinoma of the bladder (n=5) or rena...

    journal_title：European urology

    pub_type： 临床试验,杂志文章

    doi：10.1016/j.eururo.2005.07.015

    authors： Peyromaure M,Scotté F,Amsellem-Ouazana D,Vieillefond A,Oudard S,Beuzeboc P

    更新日期：2005-11-01 00:00:00

  • Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.

    abstract：BACKGROUND:To determine the anatomic extent of pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients at the time of radical prostatectomy (RP), knowledge about the topography of lymph node (LN) metastases is required. OBJECTIVE:Because small-volume LN metastases may be missed by standard histopathologi...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2013.02.007

    authors： Heck MM,Retz M,Bandur M,Souchay M,Vitzthum E,Weirich G,Mollenhauer M,Schuster T,Autenrieth M,Kübler H,Maurer T,Thalgott M,Herkommer K,Gschwend JE,Nawroth R

    更新日期：2014-08-01 00:00:00

  • Peritoneum-preserving radical nephrectomy in a patient on continuous ambulatory peritoneal dialysis.

    abstract：:We describe a pararectus retroperitoneal approach for radical nephrectomy in a patient on chronic ambulatory peritoneal dialysis. This approach allows early ligation of the renal pedicle pre-operatively and immediate resumption of peritoneal dialysis post-operatively. ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000474829

    authors： Creagh T,Grace P,Bouchier-Hayes D,McLean P

    更新日期：1992-01-01 00:00:00

  • Safety and efficacy of alprostadil sterile powder (S. Po., CAVERJECT) in diabetic patients with erectile dysfunction.

    abstract：OBJECTIVES:To evaluate the long-term efficacy and safety of intracavernosal alprostadil (CAVERJECT((R))) in diabetic patients with erectile dysfunction (ED). PATIENTS AND METHODS:This study included 31 diabetic men (aged 44-75 years) with ED of >/=4 months duration. All patients were initially instructed in the self-i...

    journal_title：European urology

    pub_type： 临床试验,杂志文章

    doi：10.1159/000020277

    authors： Tsai YS,Lin JS,Lin YM

    更新日期：2000-08-01 00:00:00

  • Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study.

    abstract：:The tendency to develop bacteriuria during the use of various forms of indwelling catheters was evaluated in a randomized trial in 90 patients. A silver alloy and hydrogel-coated Foley catheter (SHC) was compared to a non-coated catheter (NC) and a catheter coated only with hydrogel (HC). Three patients (10%) with SHC...

    journal_title：European urology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1159/000464046

    authors： Liedberg H,Lundeberg T,Ekman P

    更新日期：1990-01-01 00:00:00

  • Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism.

    abstract：:Bone mineral content (BMC) was measured with the Norland Cameron apparatus in 120 renal stone formers (RSF) with idiopathic stone disease and in 41 patients with primary hyperparathyroidism. RSF were classified, according to an oral calcium load test, into three groups: no hypercalciuria (HC; 41 cases); absorptive HC ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000474039

    authors： Fuss M,Gillet C,Simon J,Vandewalle JC,Schoutens A,Bergmann P

    更新日期：1983-01-01 00:00:00

  • Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation.

    abstract：OBJECTIVE(S):To compare the outcome of patients with stage D1 (TxN+M0) prostate cancer undergoing radical prostatectomy or androgen deprivation alone. PATIENTS AND METHODS:Eighty-two patients treated for lymph node positive prostate cancer were retrospectively analyzed for time to progression, tumor-specific and overa...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/s0302-2838(02)00134-3

    authors： Grimm MO,Kamphausen S,Hugenschmidt H,Stephan-Odenthal M,Ackermann R,Vögeli TA

    更新日期：2002-06-01 00:00:00

  • Robot-assisted Radical Prostatectomy Using Single-port Perineal Approach: Technique and Single-surgeon Matched-paired Comparative Outcomes.

    abstract：BACKGROUND:Radical perineal prostatectomy (RPP) has been revived with the advent of single-port (SP) robotic surgery. However, its interest and precise role need to be evaluated and better defined. OBJECTIVE:To describe in detail the technique of SP-RPP and compare initial perioperative outcomes with those of multipor...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2020.12.013

    authors： Lenfant L,Garisto J,Sawczyn G,Wilson CA,Aminsharifi A,Kim S,Schwen Z,Bertolo R,Kaouk J

    更新日期：2020-12-20 00:00:00

  • Bard BTA test compared with voided urine cytology in the diagnosis of recurrent bladder cancer.

    abstract：OBJECTIVE:To compare the Bard BTA (bladder tumour antigen) test with voided urine cytology (VUC) in the diagnosis of recurrent bladder cancer (BC). METHODS:Urine specimens for the BTA test and VUC were collected on the same day as before cystoscopy from patients undergoing routine surveillance cystoscopy for recurrent...

    journal_title：European urology

    pub_type： 杂志文章

    doi：

    authors： Leyh H,Mazeman E

    更新日期：1997-01-01 00:00:00

  • Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.

    abstract：CONTEXT:The outcome prediction for renal cell cancer (RCC) remains controversial, and although many parameters have been tested for prognostic significance, only a few have achieved widespread acceptance in clinical practice. The TNM staging system defines local extension of the primary tumour (T), involvement of regio...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2009.06.036

    authors： Moch H,Artibani W,Delahunt B,Ficarra V,Knuechel R,Montorsi F,Patard JJ,Stief CG,Sulser T,Wild PJ

    更新日期：2009-10-01 00:00:00

  • The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.

    abstract：BACKGROUND:The prognostic impact of primary tumor location on outcomes for patients with upper-tract urothelial carcinoma (UTUC) is still contentious. OBJECTIVE:To test the association between tumor location and disease recurrence and cancer-specific survival (CSS) in patients treated with radical nephroureterectomy (...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2010.07.003

    authors： Favaretto RL,Shariat SF,Chade DC,Godoy G,Adamy A,Kaag M,Bochner BH,Coleman J,Dalbagni G

    更新日期：2010-10-01 00:00:00

  • Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?

    abstract：:In previous reports, neuron-specific enolase (NSE) has been considered to be a useful tumor marker in renal cell carcinoma (RCC). This led us to perform a prospective clinical trial in this field. NSE was checked as a tumor marker for diagnosis and monitoring of patients with RCC. We report on 55 patients and their NS...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000474336

    authors： Gross AJ,Michl UH,Bornhöft G,Dieckmann KP

    更新日期：1993-01-01 00:00:00

  • Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique).

    abstract：OBJECTIVE:The purpose of the present study was to evaluate the length of telomeres in patients with bladder cancer using a quantitative flow cytometry (flow-FISH) technique. METHODS:Bladder washing samples from 51 patients with bladder cancer were obtained immediately before transurethral resection. The average length...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2005.04.030

    authors： Fernandez-Gomez J,Escaf Barmadah S,Gosalbez D,Rodriguez-Faba O,Jalon A,Gonzalez R,Garcia Miralles T,Calas A

    更新日期：2005-09-01 00:00:00

  • Nanotechnology and its relevance to the urologist.

    abstract：OBJECTIVES:We review important aspects of nanotechnology, and discuss the wide range of research and clinical applications of nanomedicine in the field of urology. There is particular emphasis on key clinical and pre-clinical studies to provide an update on recent and potential applications in the care of urological pa...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2007.04.065

    authors： Gommersall L,Shergill IS,Ahmed HU,Hayne D,Arya M,Patel HR,Hashizume M,Gill IS

    更新日期：2007-08-01 00:00:00

  • Lymphoedema in urological cancer.

    abstract：OBJECTIVES:To review the evidence underlying the diagnosis, pathology and treatment of lymphoedema of the lower extremities and genitalia from or following the treatment for urological cancer, and to suggest possible underlying pathophysiological mechanisms that may explain its development. METHODS:Reviews of the epid...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2003.08.010

    authors： Okeke AA,Bates DO,Gillatt DA

    更新日期：2004-01-01 00:00:00

  • Pretreatment tables predicting pathologic stage of locally advanced prostate cancer.

    abstract：BACKGROUND:Pretreatment tables for the prediction of pathologic stage have been published and validated for localized prostate cancer (PCa). No such tables are available for locally advanced (cT3a) PCa. OBJECTIVE:To construct tables predicting pathologic outcome after radical prostatectomy (RP) for patients with cT3a ...

    journal_title：European urology

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.eururo.2014.03.013

    authors： Joniau S,Spahn M,Briganti A,Gandaglia G,Tombal B,Tosco L,Marchioro G,Hsu CY,Walz J,Kneitz B,Bader P,Frohneberg D,Tizzani A,Graefen M,van Cangh P,Karnes RJ,Montorsi F,van Poppel H,Gontero P,European Multicenter Prost

    更新日期：2015-02-01 00:00:00

  • Renal lesions in Von Hippel-Lindau disease: the benign, the malignant, the unknown.

    abstract：OBJECTIVES:To describe the features and treatment of renal lesions in von Hippel-Lindau disease (VHL) from a series of patients, to highlight important issues in the management of these lesions. MATERIALS AND METHODS:We performed a retrospective study in 7 patients with VHL who underwent surgery for renal lesions betw...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000019771

    authors： Salomé F,Colombeau P,Fermeaux V,Cazaux P,Dumas JP,Pfeifer P,Moreau JJ,Richard S,Labrousse F

    更新日期：1998-01-01 00:00:00